SomaLogic Inc. (NASDAQ:SLGC) has seen 1.13 million shares traded in the last trading session. The company, currently valued at $656.83M, closed the last trade at $3.35 per share which meant it lost -$0.06 on the day or -1.76% during that session. The SLGC stock price is -339.4% off its 52-week high price of $14.72 and 0.6% above the 52-week low of $3.33. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.88 million shares traded. The 3-month trading volume is 1.77 million shares.
The consensus among analysts is that SomaLogic Inc. (SLGC) is a Buy stock at the moment, with a recommendation rating of 1.20. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 4 have rated it as a Hold, with 4 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -$0.18.
SomaLogic Inc. (NASDAQ:SLGC) trade information
Sporting -1.76% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on Tuesday, 09/20/22 when the SLGC stock price touched $3.35 or saw a rise of 13.44%. Year-to-date, SomaLogic Inc. shares have moved -71.22%, while the 5-day performance has seen it change -11.61%. Over the past 30 days, the shares of SomaLogic Inc. (NASDAQ:SLGC) have changed -12.99%. Short interest in the company has seen 12.13 million shares shorted with days to cover at 5.18.
Wall Street analysts have a consensus price target for the stock at $7.75, which means that the shares’ value could jump 56.77% from current levels. The projected low price target is $5.00 while the price target rests at a high of $9.00. In that case, then, we find that the current price level is -168.66% off the targeted high while a plunge would see the stock gain -49.25% from current levels.
SomaLogic Inc. (SLGC) estimates and forecasts
Figures show that SomaLogic Inc. shares have underperformed across the wider relevant industry. The company’s shares have lost -58.69% over the past 6 months, with this year growth rate of 8.93%, compared to 13.50% for the industry. Revenue growth from the last financial year stood is estimated to be 31.00%.
4 analysts offering their estimates for the company have set an average revenue estimate of $24.82 million for the current quarter. 4 have an estimated revenue figure of $27.47 million for the next quarter concluding in Sep 2022.
SomaLogic Inc. is expected to release its next earnings report on November 15 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
SomaLogic Inc. (NASDAQ:SLGC)’s Major holders
Insiders own 13.71% of the company shares, while shares held by institutions stand at 60.34% with a share float percentage of 69.93%. Investors are also buoyed by the number of investors in a company, with SomaLogic Inc. having a total of 150 institutions that hold shares in the company. The top two institutional holders are Casdin Capital, LLC with over 12.39 million shares worth more than $99.36 million. As of Mar 30, 2022, Casdin Capital, LLC held 6.80% of shares outstanding.
The other major institutional holder is Madryn Asset Management, Lp, with the holding of over 7.47 million shares as of Mar 30, 2022. The firm’s total holdings are worth over $59.9 million and represent 4.10% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are ARK ETF Tr-ARK Genomic Revolution ETF and Price (T.Rowe) Health Sciences Fund. As of Jun 29, 2022, the former fund manager holds about 4.72% shares in the company for having 8.6 million shares of worth $38.86 million while later fund manager owns 4.72 million shares of worth $37.84 million as of Mar 30, 2022, which makes it owner of about 2.59% of company’s outstanding stock.